Резюме
Definition
Anamnesis y examen
Principales factores de diagnóstico
- diarrhea
- history of travel, contact with contaminated food, or contact with infected person
Otros factores de diagnóstico
- abdominal pain or discomfort
- volume depletion
- fever
- nausea/vomiting
- anorexia
- lethargy
Factores de riesgo
- ingestion of contaminated food products or water
- travel
- poor hygiene practices
- infantile or advanced age (<5 years and >65 years)
- contact history
- immunocompromised state
- contact with infected animals
Pruebas diagnósticas
Primeras pruebas diagnósticas para solicitar
- stool cultures
- CBC
- renal function and electrolytes
Pruebas diagnósticas que deben considerarse
- identification of Shiga toxin-producing E coli infection
- blood cultures
- inflammatory markers (CRP and/or erythrocyte sedimentation rate)
- abdominal x-ray
- endoscopy
- abdominal CT scan
Algoritmo de tratamiento
suspected foodborne illness
confirmed enterotoxigenic positive
confirmed enterohemorrhagic positive
other Escherichia coli serotypes
Colaboradores
Autores
Eli D. Ehrenpreis, MD, FACG, AGAF
Reaserch Director
Internal Medicine Residency
Advocate Lutheran General Hospital
Park Ridge
IL
Professor of Medicine
Wake Forest University Medical School
Winston-Salem
NC
Divulgaciones
EDE is CEO, owner, and shareholder for E2Bio Life Sciences LLC. E2Bio Life Sciences LLC has developed Bocaliner, an FDA-registered class 1 medical device designed to enhance the efficacy of topical medications applied to the oral cavity. EDE is the inventor and owner of patents for this device. EDE is also a CEO of G.I. Pharmaceuticals Inc., which has medical treatments for oral leukoplakia designed to prevent oral cancer, and a new medication for anal pruritus. G.I. Pharmaceuticals Inc. is involved with the development of educational programs for students and medical trainees.
Agradecimientos
Dr Eli D. Ehrenpreis would like to gratefully acknowledge the assistance of Dr Olivia Foy, who contributed to this update. Dr Eli D. Ehrenpreis would like to gratefully acknowledge Dr Olivia Foy, Dr Alexandra Kent, and the late Professor Satish Keshav, the previous contributors to this topic.
Divulgaciones
OF and AK declare that they have no competing interests.
Revisores por pares
Andrew Poullis, BSc, MBBS, MD, FRCP
Consultant Gastroenterologist
St George’s Hospital
London
UK
Divulgaciones
AP declares that he has no competing interests.
Fiona Cooke, MA, PhD, MSc, FRCPath, MRCP, DTM&H
Research Fellow and Medical Microbiologist
Wellcome Trust Sanger Institute
Department of Microbiology
Addenbrooke's Hospital
Cambridge
UK
Divulgaciones
FC declares that she has no competing interests.
Houssam E. Mardini, MD, MPH, FACP
Voluntary Assistant Professor of Medicine
Digestive Health & Nutrition Center of Ashland
Ashland
KY
Divulgaciones
HEM declares that he has no competing interests.
Agradecimiento de los revisores por pares
Los temas de BMJ Best Practice se actualizan de forma continua de acuerdo con los desarrollos en la evidencia y en las guías. Los revisores por pares listados aquí han revisado el contenido al menos una vez durante la historia del tema.
Divulgaciones
Las afiliaciones y divulgaciones de los revisores por pares se refieren al momento de la revisión.
Referencias
Artículos principales
Shane AL, Mody RK, Crump JA, et al. 2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea. Clin Infect Dis. 2017 Nov 29;65(12):e45-80.Texto completo Resumen
Centers for Disease Control and Prevention. CDC Yellow Book 2026: health information for international travel: preparing international travelers - travelers' diarrhea. 2025 [internet publication].Texto completo
Artículos de referencia
Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
Diferenciales
- Viral gastroenteritis
- Alternative foodborne bacterial gastroenteritis/traveler's diarrhea
- Amebiasis
Más DiferencialesGuías de práctica clínica
- E. coli (Escherichia coli) infection
- Infectious diarrhea - guideline for investigation
Más Guías de práctica clínicaFolletos para el paciente
Diarrhea in adults
Diarrhea in children
Más Folletos para el pacienteInicie sesión o suscríbase para acceder a todo el BMJ Best Practice
El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad